Home/Filings/4/0001125345-25-000020
4//SEC Filing

Eck Stephen L. 4

Accession 0001125345-25-000020

CIK 0001125345other

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 8:34 PM ET

Size

389.8 KB

Accession

0001125345-25-000020

Insider Transaction Report

Form 4
Period: 2025-02-07
Eck Stephen L.
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2025-02-08$2.60/sh3,312$8,61117,654 total
  • Award

    Restricted Stock Unit

    2025-02-07+19,00019,000 total
    Common Stock (19,000 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-0811,16822,332 total
    Exercise: $0.00Common Stock (11,168 underlying)
  • Exercise/Conversion

    Common Stock

    2025-02-08+11,16820,966 total
  • Award

    Employee Stock Option (right to buy)

    2025-02-07+113,000113,000 total
    Exercise: $2.60Exp: 2035-02-07Common Stock (113,000 underlying)
Footnotes (3)
  • [F1]On February 8, 2024 the reporting person was granted 33,500 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.
  • [F2]12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
  • [F3]Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

Issuer

MACROGENICS INC

CIK 0001125345

Entity typeother

Related Parties

1
  • filerCIK 0001669041

Filing Metadata

Form type
4
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 8:34 PM ET
Size
389.8 KB